AACR Meetings Feature Latest Advances in Blood Cancer Research
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells...
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells...
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
Multiple myeloma is a cancer of antibody-producing cells—called plasma cells—that accounts for approximately 1.8 percent of new cancer cases...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the bone marrow and the blood that develops in either...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....